| |
Consecutive cases (16) |
SPLC (10) |
| Gender |
|
|
| Male |
12 (75.0%) |
9 (90%) |
| Female |
4 (25.0%) |
1 (10%) |
| Mean age (years) |
70 |
70.5 |
| Previous surgery |
11 (68,8%) |
10 (100%) |
| lobectomy |
9 (56.3%) |
8 (80%) |
| pneumonectomy |
2 (12.5%) |
2 (20%) |
| Histology |
18 |
12 |
| adenocarcinoma |
7 (38.9%) |
5 (41.6%) |
| squamouscell |
6 (33.3%) |
2 (16.7%) |
| notconclusive |
3 (16.7%) |
3 (25%) |
| notperformed |
2 (11.1%) |
2 (16.7%) |
| Stage |
|
|
| Ia |
10 (62.4%) |
7 (70%) |
| Ib |
3 (18.8%) |
1 (10%) |
| IIa,b |
0 |
0 |
| IIIa |
3 (18.8%) |
2 (20%) |
| Localisation |
18 |
12 |
| central |
2 (11.1%) |
1 (8.3%) |
| peripheral |
16 (88.9%) |
11 (91.7%) |
| Multiple ipsilateral tumors |
2 (12.5%) |
2 (10%) |
| Malignancy presentation |
|
|
| metachrounous |
5 (31.3%) |
5 (50%) |
| synchronous |
2 (12.5%) |
2 (20%) |
| synchronousor metastasis of primary lung cancer |
3 (18.8%) |
3 (30%) |
| primary |
5 (31.2%) |
0 |
| metastasis of primary lung cancer |
1 (6.2%) |
0 |
| Oncological comorbidities |
4 (25%) |
2 (20%) |
| Previous radiation therapy and chemotherapy for primary lung cancer |
3 (18.8%) |
2 (20%) |
|
